Secondary Logo

Journal Logo

Articles by Isabelle Côté, BSc

Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause

Labrie, Fernand; Archer, David F.; Koltun, William; More

Menopause. 25(11):1339-1353, November 2018.

Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause

Labrie, Fernand; Archer, David F.; Koltun, William; More

Menopause. 23(3):243-256, March 2016.

Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone)

Archer, David F.; Labrie, Fernand; Bouchard, Céline; More

Menopause. 22(9):950-963, September 2015.

Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration

Labrie, Fernand; Archer, David; Bouchard, Céline; More

Menopause. 16(5):897-906, September-October 2009.

Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy

Labrie, Fernand; Archer, David; Bouchard, Céline; More

Menopause. 16(5):907-922, September-October 2009.

Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women

Labrie, Fernand; Archer, David; Bouchard, Céline; More

Menopause. 16(5):923-931, September-October 2009.

Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women

Labrie, Fernand; Cusan, Leonello; Gomez, José-Luis; More

Menopause. 16(1):30-36, January 2009.